Новые возможности диагностики некоронарогенных поражений миокарда: роль магнитно-резонансной томографии
References
1. Беленков Ю. Н. Терновой С. К., Синицын В. Е. Магнитно-резонансная томография сердца и сосудов. - М.: Видар, 1997. - 142 с.2. Синицын В. Е. Терновой С. К. Магнитно-резонансная томография в новом столетии // Радиология-практика. - 2005. - № 4. - С. 17-22.
3. Ринкк П. А. Магнитный резонанс в медицине. - М., Гэотар-Мед, 2003.
4. Грамович В. В. Синицын В. Е., Гордин М. П. и др. Количественная оценка перфузии миокарда с помощью магнитно-резонансной томографии // Кардиология. - 2004. - № 8. - С. 4-12.
5. Friedrich M. G., Strohm O., Schulz-Menger J. et al. Contrast media-enhanced magnetic resonance imaging visualizes myocardial changes in the course of viral myocarditis // Circulation. - 1998. - Vol. 97. - P. 1802-1809.
6. Mahrholdt H., Goedecke C., Wagner A. et al. Cardiovascular magnetic resonance assessment of human myocarditis: a comparison to histology and molecular pathology // Ibid. - 2004. - Vol. 109. - P. 1250-1258.
7. Vignaux O., Dhote R., Duboc D. et al. Clinical significance of myocardial magnetic resonance abnormalities in patients with sarcoidosis: a 1-year followup study // Chest. - 2002. - Vol. 122. - P. 1895-1901.
8. Chandra M., Silverman M. E., Oshinski J. et al. Diagnosis of cardiac sarcoidosis aided by MRI // Ibid. - 1996. - Vol. 110. - P. 562-565.
9. Dupuis J. M., Victor J., Furber A. et al. [Value of magnetic resonance imaging in cardiac sarcoidosis. Apropos of a case // Arch. Mal. Coeur. Vaiss. - 1994. - Vol. 87. - P. 105-110.
10. Matsuki M., Matsuo M. MR findings of myocardial sarcoidosis // Clin Radiol. - 2000. - Vol. 55. - P. 323-325.
11. Schulz-Menger J., Strohm O., Dietz R. et al. Visualization of cardiac involvement in patients with systemic sarcoidosis applying contrast-enhanced magnetic resonance imaging // Magma. - 2000. - Vol. 11. - P. 82-83.
12. Shimada T., Shimada K., Sakane T. et al. Diagnosis of cardiac sarcoidosis and evaluation of the effects of steroid therapy by gadolinium-DTPA-enhanced magnetic resonance imaging // Amer. J. Med. - 2001. - Vol. 110. - P. 520-527.
13. Rahman J. E., Helou E. F., Gelzer-Bell R. et al. Noninvasive diagnosis of biopsy-proven cardiac amyloidosis // J. Amer. Coll. Cardiol. - 2004. - Vol. 43. - P. 410-415.
14. Kwong R. Y., Falk R. H. Cardiovascular magnetic resonance in cardiac amyloidosis // Circulation. - 2005. - Vol. 111. - P. 122-124.
15. Maceira A. M., Joshi J., Prasad S. K. et al. Cardiovascular magnetic resonance in cardiac amyloidosis // Ibid. - 2005. - Vol. 111. - P. 186-193.
16. Crilley J. G., Boehm E. A., Blair E. et al. Hypertrophic cardiomyopathy due to sarcomeric gene mutations is characterized by impaired energy metabolism irrespective of the degree of hypertrophy // J. Amer. Coll. Cardiol. - 2003. - Vol. 41. - P. 1776-1782.
17. Maron B. J. Hypertrophic cardiomyopathy: a systematic review // JAMA. - 2002. - Vol. 287. - P. 1308-1320.
18. Allison J. D., Flickinger F. W., Wright J. C. et al. Measurement of left ventricular mass in hypertrophic cardiomyopathy using MRI: comparison with echocardiography // Magn. Reson. Imaging. - 1993. - Vol. 11. - P. 329-334.
19. Farmer D., Higgins C. B., Yee E. et al. Tissue characterization by magnetic resonance imaging in hypertrophic cardiomyopathy // Amer. J. Cardiol. - 1985. - Vol. 55. - P. 230-232.
20. Gaudio C., Pelliccia F., Tanzilli G. et al. Magnetic resonance imaging for assessment of apical hypertrophy in hypertrophic cardiomyopathy // Clin. Cardiol. - 1992. - Vol. 15. - P. 164-168.
21. Higgins C. B., Byrd B. F., Stark D. et al. Magnetic resonance imaging in hypertrophic cardiomyopathy // Amer. J. Cardiol. - 1985. - Vol. 55. - P. 1121-1126.
22. Arrive L., Assayag P., Russ G. et al. MRI and cine MRI of asymmetric septal hypertrophic cardiomyopathy // J. Comput. Assist. Tomogr. - 1994. - Vol. 18. - P. 376-382.
23. Bogaert J., Goldstein M., Tannouri F. et al. Late myocardial enhancement in hypertrophic cardiomyopathy with contrast-enhanced MR imaging // Amer. J. Roentgenol. - 2003. - Vol. 180. - P. 981-985.
24. Maron B. J. Cardiology patient pages. Hypertrophic cardiomyopathy // Circulation. - 2002. - Vol. 106. - P. 2419-2421.
25. Koito H., Suzuki J., Nakamori H. et al. Clinical significance of abnormal high signal intensity of left ventricular myocardium by gadolinium-diethylenetriaminepenta- acetic acid enhanced magnetic resonance imaging in hypertrophic cardiomyopathy // J. Cardiol. - 1995. - Vol. 25. - P. 163-170.
26. Amano Y., Takayama M., Takahama K. et al. Delayed hyper-enhancement of myocardium in hypertrophic cardiomyopathy with asymmetrical septal hypertrophy: comparison with global and regional cardiac MR imaging appearances // J. Magn. Reson. Imaging. - 2004. - Vol. 20. - P. 595-600.
27. Choudhury L., Mahrholdt H., Wagner A. et al. Myocardial scarring in asymptomatic or mildly symptomatic patients with hypertrophic cardiomyopathy // J. Amer. Coll. Cardiol. - 2002. - Vol. 40. - P. 2156-2164.
28. Debl K., Djavidani B., Buchner S. et al. Delayed hyperenhancement in magnetic resonance imaging of left ventricular hypertrophy caused by aortic stenosis and hypertrophic cardiomyopathy: visualisation of focal fibrosis // Heart. - 2006. - Vol. 92. - P. 1447-1451.
29. Dumont C. A., Monserrat L., Soler R. et al. Clinical significance of late gadolinium enhancement on cardiovascular magnetic resonance in patients with hypertrophic cardiomyopathy // Rev. Esp. Cardiol. - 2007. - Vol. 60. - P. 15-23.
30. Matsunaka T., Hamada M., Matsumoto Y. et al. First-pass myocardial perfusion defect and delayed contrast enhancement in hypertrophic cardiomyopathy assessed with MRI // Magn. Reson. Med. Sci. - 2003. - Vol. 2. - P. 61-69.
31. Moon J. C., McKenna W. J., McCrohon J. A. et al. Toward clinical risk assessment in hypertrophic cardiomyopathy with gadolinium cardiovascular magnetic resonance // J. Amer. Coll. Cardiol. - 2003. - Vol. 41. - P. 1561-1567.
32. Soler R., Rodriguez E., Monserrat L. et al. Magnetic resonance imaging of delayed and contractile function // J. Comput. Assist. Tomogr. - 2006. - Vol. 30. - P. 412-420.
33. Kim R. J., Judd R. M. Gadolinium-enhanced magnetic resonance imaging in hypertrophic cardiomyopathy: in vivo imaging of the pathologic substrate for premature cardiac death? // J. Amer. Coll. Cardiol. - 2003. - Vol. 41. - P. 1568-1572.